Trial Outcomes & Findings for Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair (NCT NCT02062437)
NCT ID: NCT02062437
Last Updated: 2017-05-31
Results Overview
* Surgical incidents. * Post-operative complications. * Failure and revisions analysis.
COMPLETED
132 participants
2-year follow-up visit
2017-05-31
Participant Flow
All patients who received the same Total Hip Replacement system for primary hip replacement between July and October 2010 were contacted for study participation.
Participant milestones
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
All patients were treated with a total hip replacement using a ceramic friction pair Biolox® delta, with a Meije Duo® cementless stem with HAP associated with a cementless double coating of plasma sprayed titanium and HAP Dynacup® acetabular cup.
|
|---|---|
|
Overall Study
STARTED
|
132
|
|
Overall Study
COMPLETED
|
80
|
|
Overall Study
NOT COMPLETED
|
52
|
Reasons for withdrawal
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
All patients were treated with a total hip replacement using a ceramic friction pair Biolox® delta, with a Meije Duo® cementless stem with HAP associated with a cementless double coating of plasma sprayed titanium and HAP Dynacup® acetabular cup.
|
|---|---|
|
Overall Study
Pt. didn't want to come for the 2y visit
|
31
|
|
Overall Study
Patient not available for the 2y visit
|
18
|
|
Overall Study
Death
|
2
|
|
Overall Study
Pt. couldn't come due to med. condition
|
1
|
Baseline Characteristics
Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair
Baseline characteristics by cohort
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=80 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
Age, Continuous
|
59.8 years
STANDARD_DEVIATION 9.0 • n=5 Participants
|
|
Sex: Female, Male
Female
|
38 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
42 Participants
n=5 Participants
|
|
Region of Enrollment
France
|
80 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2-year follow-up visitPopulation: The total of 80 patients were seen for their 2-Year follow-up visit.
* Surgical incidents. * Post-operative complications. * Failure and revisions analysis.
Outcome measures
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=80 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
Number of Participants With Adverse Events
|
2 participants
|
SECONDARY outcome
Timeframe: BaselinePopulation: 80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities
Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°). Normal values (usually observed range of motions) are: extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°). Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.
Outcome measures
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=45 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
General Performance: Mobility
Extension
|
-1 Degrees
Standard Deviation 6
|
|
General Performance: Mobility
Flexion
|
89 Degrees
Standard Deviation 12
|
|
General Performance: Mobility
Adduction
|
17 Degrees
Standard Deviation 9
|
|
General Performance: Mobility
Abduction
|
20 Degrees
Standard Deviation 10
|
|
General Performance: Mobility
External rotation
|
20 Degrees
Standard Deviation 9
|
|
General Performance: Mobility
Internal rotation
|
7 Degrees
Standard Deviation 13
|
SECONDARY outcome
Timeframe: 2-year Follow-up visitPopulation: 80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities
Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°). Normal values (usually observed range of motions) are: extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°). Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.
Outcome measures
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=45 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
General Performance: Mobility
Extension
|
0 Degrees
Standard Deviation 1
|
|
General Performance: Mobility
Flexion
|
107 Degrees
Standard Deviation 13
|
|
General Performance: Mobility
Adduction
|
26 Degrees
Standard Deviation 9
|
|
General Performance: Mobility
Abduction
|
34 Degrees
Standard Deviation 9
|
|
General Performance: Mobility
External rotation
|
30 Degrees
Standard Deviation 7
|
|
General Performance: Mobility
Internal rotation
|
21 Degrees
Standard Deviation 9
|
OTHER_PRE_SPECIFIED outcome
Timeframe: BaselinePopulation: Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.
Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).
Outcome measures
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=77 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
General Performance: Objective Clinical Score (PMA)
Pain score
|
1.9 score on a scale
Standard Deviation 1.1
|
|
General Performance: Objective Clinical Score (PMA)
Mobility score
|
5.1 score on a scale
Standard Deviation 0.9
|
|
General Performance: Objective Clinical Score (PMA)
Walking score
|
4.5 score on a scale
Standard Deviation 0.7
|
|
General Performance: Objective Clinical Score (PMA)
Total PMA score
|
11.5 score on a scale
Standard Deviation 1.7
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 2-year follow-up visitPopulation: Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.
Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).
Outcome measures
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=77 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
General Performance: Objective Clinical Score (PMA)
Pain score
|
5.8 score on a scale
Standard Deviation 0.6
|
|
General Performance: Objective Clinical Score (PMA)
Mobility score
|
6.0 score on a scale
Standard Deviation 1.0
|
|
General Performance: Objective Clinical Score (PMA)
Walking score
|
5.9 score on a scale
Standard Deviation 0.5
|
|
General Performance: Objective Clinical Score (PMA)
Total PMA score
|
17.7 score on a scale
Standard Deviation 1.0
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 2-year Follow-up visitPopulation: Patients with X-ray data available
Radiological assessment is based on : * Cup radiological signs of osteolysis or radiolucencies. * Stem radiological signs of osteolysis or radiolucencies. * Ossifications according to Brooker classification from class I: Ossification around the hip joint. to class IV: shows apparent bone ankylosis of the hip. (i.e Class 0 = no ossification) * Other Radiological signs
Outcome measures
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=80 Participants
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 4)
|
0 participants
|
|
General Performance: Radiological Assessment.
Other radiological signs
|
0 participants
|
|
General Performance: Radiological Assessment.
Cups without radiological signs
|
80 participants
|
|
General Performance: Radiological Assessment.
Stems without radiological signs
|
80 participants
|
|
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 0)
|
70 participants
|
|
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 1)
|
6 participants
|
|
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 2)
|
2 participants
|
|
General Performance: Radiological Assessment.
Ossifications (Brooker classification = 3)
|
2 participants
|
Adverse Events
Total Hip Replacement Using a Ceramic Friction Pair
Serious adverse events
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=80 participants at risk
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Femoral fracture
|
1.2%
1/80 • Number of events 1 • 2 years
Adverse events were collected from surgery to last follow-up visit
|
Other adverse events
| Measure |
Total Hip Replacement Using a Ceramic Friction Pair
n=80 participants at risk
Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup
|
|---|---|
|
Musculoskeletal and connective tissue disorders
Fracture during surgery
|
1.2%
1/80 • Number of events 1 • 2 years
Adverse events were collected from surgery to last follow-up visit
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60